Overview Dividends

AKBA Performance & Benchmarks - -14% in 12m

The Total Return for 3m is -50.6%, for 6m -47.3% and YTD -19%. Compare with Peer-Group: Biotechnology

Performance Rating 55.35%
#67 in Peer-Group
Rel. Strength 22.62%
#5904 in Stock-Universe
Total Return 12m -13.97%
#23 in Peer-Group
Total Return 5y -49.84%
#29 in Peer-Group
P/E Value
P/E Trailing 0.00
P/E Forward 9.23
High / Low USD
52 Week High 4.01 USD
52 Week Low 1.54 USD
Sentiment Value
VRO Trend Strength +-100 4.98
Buy/Sell Signal +-5 -2.19
Support / Resistance Levels
Support
Resistance
12m Total Return: AKBA (-14%) vs XBI (21.1%)
Total Return of Akebia Ther versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for AKBA Performance & Benchmarks - -14% in 12m

Top 5 Performer in Biotechnology (200)

Short Term Performance

Symbol 1w 1m 3m
AKBA -12.5% -51.3% -50.6%
SPRB -1.39% -25.1% 1,226%
OLMA 177% 183% 304%
GLTO -37.7% 84.0% 413%
CDTX 107% 118% 238%
INBX 7.0% 109% 227%

Long Term Performance

Symbol 6m 12m 5y
AKBA -47.3% -14.0% -49.8%
RGC 6.68% 8,313% 4,468%
ABVX 2,019% 1,287% 959%
ABVX 1,949% 1,210% 365%
CDTX 716% 1,352% 384%
CELC 783% 636% 918%

Overall best picks of Peer Group - selected by GARP Metrics, sorted by Growth Rating

Symbol Market Cap 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CTMX NASDAQ
CytomX Therapeutics		 657M 0.80% 333% -48.5% 12.9 14.2 -1.80 49.0% 303%

Performance Comparison: AKBA vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AKBA
Total Return (including Dividends) AKBA XBI S&P 500
1 Month -51.27% 3.32% -2.80%
3 Months -50.64% 27.62% 2.54%
6 Months -47.26% 39.89% 10.70%
12 Months -13.97% 21.14% 11.85%
5 Years -49.84% -9.69% 95.81%

Trend Stabilty (consistency of price movement) AKBA XBI S&P 500
1 Month -94.2% 67.8% -60.6%
3 Months -67.7% 97.2% 75%
6 Months -73.3% 97.8% 96.5%
12 Months 50.4% 25.6% 73.8%
5 Years -7.6% -33.7% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month 1 %th -52.83% -49.86%
3 Month 1 %th -61.32% -51.87%
6 Month 2 %th -62.30% -52.36%
12 Month 23 %th -28.98% -23.08%
5 Years 30 %th -44.45% -74.38%

FAQs

Does Akebia Ther (AKBA) outperform the market?

No, over the last 12 months AKBA made -13.97%, while its related Sector, the SPDR S&P Biotech (XBI) made 21.14%. Over the last 3 months AKBA made -50.64%, while XBI made 27.62%.

Performance Comparison AKBA vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe
AKBA vs. Indices Symbol 1w 1m 6m 12m
US S&P 500 SPY -9.6% -48.5% -58% -26%
US NASDAQ 100 QQQ -8.8% -47% -60.1% -31%
German DAX 40 DAX -9.4% -47.2% -44% -36%
Shanghai Shenzhen CSI 300 CSI 300 -9.1% -50.8% -66.4% -32%
Hongkong Hang Seng HSI -7% -52.3% -63.5% -45%
India NIFTY 50 INDA -13.5% -51.2% -48.5% -17%
Brasil Bovespa EWZ -9.2% -56.8% -62.7% -39%
AKBA vs. Sectors Symbol 1w 1m 6m 12m
Communication Services XLC -10.8% -45.9% -56.1% -28%
Consumer Discretionary XLY -7.8% -44.9% -50% -18%
Consumer Staples XLP -12.2% -48% -41.8% -13%
Energy XLE -10.7% -53.5% -55.3% -9%
Financial XLF -9% -48.1% -47.5% -19%
Health Care XLV -11.6% -55.9% -60.7% -22%
Industrial XLI -9.8% -47.6% -50.8% -22%
Materials XLB -9% -46.2% -45.2% -7%
Real Estate XLRE -11.4% -46.3% -45.3% -10%
Technology XLK -7.5% -45.7% -64.1% -32%
Utilities XLU -11.8% -47.4% -55.1% -27%
Aerospace & Defense XAR -8.8% -41.9% -63.6% -45%
Biotech XBI -14.2% -54.6% -87.2% -35%
Homebuilder XHB -8% -42.9% -48.4% 0%
Retail XRT -8.5% -42.4% -48.6% -15%
AKBA vs. Commodities Symbol 1w 1m 6m 12m
Oil USO -12.9% -54.7% -49.4% -11%
Natural Gas UNG -9.9% -62.8% -32.1% -12%
Gold GLD -10.4% -44.3% -70.7% -67%
Silver SLV -9% -47.2% -99.2% -77%
Copper CPER -10.9% -49.8% -52.5% -32%
AKBA vs. Bonds Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -12.3% -49.1% -54.1% -17%
iShares High Yield Corp. Bond HYG -12.4% -50.8% -51.2% -21%